LauraHutchinsMD

Oncology • Little Rock, AR

Professor of Medicine, University Ark

Join to view full profile

Dr. Hutchins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hutchins' full profile

Already have an account?

Office
4301 W Markham St # 783
Little Rock, AR 72205
Phone+1 501-686-8000

Education & Training

University of Arkansas for Medical SciencesFellowship, Hematology and Medical Oncology, 1980 - 1983
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1977 - 1980
University of Arkansas For Medical Sciences College of MedicineClass of 1977

Certifications & Licensure

AR State Medical License 1977 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Redbook Magazine: Top Breast Cancer Doctors Castle Connolly, 2001
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis Start of enrollment: 1996 Nov 01
Completed
Phase 2
Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma Start of enrollment: 2001 Nov 01
Completed
Phase 2
S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2005 Jun 01
Completed
Phase 2
Vaccination of High Risk Breast Cancer Patients Start of enrollment: 2011 Jul 01
Completed
Phase 1
Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase Inhibitors Start of enrollment: 2011 Apr 01
Completed
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients Start of enrollment: 2012 Feb 01
Active, not recruiting
Phase 2
In Vivo Real-time Detection of Circulating Melanoma Cells Start of enrollment: 2013 Feb 01
Recruiting
Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer Start of enrollment: 2013 Sep 06
Completed
Phase 1
Vaccination of High Risk Breast Cancer Patients Start of enrollment: 2015 Jan 14
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Racial Disparity in Adherence to Endocrine Therapy among Women with Early-Stage Hormone Receptor Positive Breast Cancer: An Analysis of Arkansas All-Payers Claims Data...
Chenghui Li, Sindhu J Malapati, Laura P James, Laura F Hutchins
Clinical Breast Cancer. 2024-10-01
1 citations
Consistency Between State's Cancer Registry and All-Payer Claims Database in Documented Radiation Therapy Among Patients Who Received Breast Conservative Surgery.
Chenghui Li, Sindhu J Malapati, John T Guire, Laura F Hutchins
JCO Clinical Cancer Informatics. 2023-01-01
13 citations
Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis.
Ahmad A. Tarhini, Ni Kang, Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen
Journal for Immunotherapy of Cancer. 2021-05-01

Press Mentions

Meadors Moves to CHI St. Vincent (Movers & Shakers)October 18th, 2021
New Cancer Center Head Feted at Murphys' HomeJanuary 26th, 2020
Michael Birrer to Lead Winthrop P. Rockefeller Cancer InstituteSeptember 13th, 2019
Join now to see all